切换至 "中华医学电子期刊资源库"

中华产科急救电子杂志 ›› 2018, Vol. 07 ›› Issue (04) : 193 -196. doi: 10.3877/cma.j.issn.2095-3259.2018.04.001

所属专题: 文献

述评

早产的预防与治疗
刘騱遥1, 漆洪波1,()   
  1. 1. 400016 重庆医科大学附属第一医院妇产科
  • 收稿日期:2018-07-24 出版日期:2018-11-18
  • 通信作者: 漆洪波
  • 基金资助:
    国家重点研发计划(2016YFC1000407)

Prevention and treatment of preterm birth

Xiyao Liu1, Hongbo Qi1()   

  • Received:2018-07-24 Published:2018-11-18
  • Corresponding author: Hongbo Qi
引用本文:

刘騱遥, 漆洪波. 早产的预防与治疗[J]. 中华产科急救电子杂志, 2018, 07(04): 193-196.

Xiyao Liu, Hongbo Qi. Prevention and treatment of preterm birth[J]. Chinese Journal of Obstetric Emergency(Electronic Edition), 2018, 07(04): 193-196.

[1]
Liu L, Oza S, Hogan D, et al. Global, regional, and national causes of under-5 mortality in 2000-15: an updated systematic analysis with implications for the Sustainable Development Goals [J]. Lancet, 2016, 388(10063): 3027-3035.
[2]
Blencowe H, Cousens S, Oestergaard M, et al. National, regional, and worldwide estimates of preterm birth rates in the year 2010 with time trends since 1990 for selected countries: a systematic analysis and implications [J]. Lancet, 2012, 379(9832): 2162-2172.
[3]
国家卫生健康委员会.早产儿保健工作规范政策解读[EB/OL].

URL    
[4]
Boyd HA, Poulsen G, Wohlfahrt J, et al. Maternal Contributions to Preterm Delivery [J]. Am J Epidemiol, 2009, 170(11): 1358-1364.
[5]
Mercer BM, Goldenberg RL, Moawad AH, et al. The Preterm Prediction Study: Effect of gestational age and cause of preterm birth on subsequent obstetric outcome [J]. Am J Obstet Gynecol, 1999, 181(5): 1216-1221.
[6]
Lykke JA, Paidas MJ, Langhoff-Roos J. Recurring Complications in Second Pregnancy [J]. Obstet Gynecol, 2009, 113: 1217.
[7]
Kristensen J, Langhoffroos J, Kristensen FB. Implications of idiopathic preterm delivery for previous and subsequent pregnancies[J]. Obstet Gynecol, 1995, 86(5): 800-804.
[8]
Laughon SK, Albert PS, Leishear K, et al. The NICHD Consecutive Pregnancies Study: recurrent preterm delivery by subtype [J]. Am J Obstet Gynecol, 2014, 210(2): 131.e1-131.e8.
[9]
Yamashita M, Hayashi S, Endo M, et al. Incidence and risk factors for recurrent spontaneous preterm birth: A retrospective cohort study in Japan [J]. J Obstet Gynaecol Res, 2015, 41(11): 1708-1714.
[10]
Wang YY, Li Q, Guo Y, et al. Association of Long-term Exposure to Airborne Particulate Matter of 1 μm or Less With Preterm Birth in China [J]. JAMA Pediatr, 2018, 8(8): e174872.
[11]
Medley N, Poljak B, Mammarella S, et al. Clinical guidelines for prevention and management of preterm birth: a systematic review [J]. BJOG, 2018, 125(11): 1361-1369.
[12]
van Baaren GJ, Vis JY, Grobman WA, et al. Cost-effectiveness analysis of cervical length measurement and fibronectin testing in women with threatened preterm labor [J]. Am J Obstet Gynecol, 2013, 209(5): 436.e1-436.e8.
[13]
Esplin MS, Elovitz MA, Iams JD, et al. Predictive Accuracy of Serial Transvaginal Cervical Lengths and Quantitative Vaginal Fetal Fibronectin Levels for Spontaneous Preterm Birth Among Nulliparous Women [J]. JAMA, 2017, 317(10): 1047-1056.
[14]
Amabebe E, Chapman DR, Stern VL, et al. Mid-gestational changes in cervicovaginal fluid cytokine levels in asymptomatic pregnant women are predictive markers of inflammation-associated spontaneous preterm birth [J]. J Reprod Immunol, 2018, 126: 1-10.
[15]
Ngo T, Moufarrej MN, Rasmussen MH, et al. Noninvasive blood tests for fetal development predict gestational age and preterm delivery [J]. Science, 2018, 360(6393): 1133-1136.
[16]
Norman JE, Marlow N, Messow CM, et al. Vaginal progesterone prophylaxis for preterm birth (the OPPTIMUM study): a multicentre, randomised, double-blind trial [J]. Lancet, 2016, 387(10033): 2106-2116.
[17]
Saccone G, Maruotti GM, Giudicepietro A, et al. Effect of Cervical Pessary on Spontaneous Preterm Birth in Women With Singleton Pregnancies and Short Cervical Length: A Randomized Clinical Trial [J]. JAMA, 2017, 318(23): 2317-2324.
[18]
Nicolaides KH, Syngelaki A, Poon LC, et al. A Randomized Trial of a Cervical Pessary to Prevent Preterm Singleton Birth [J]. N Engl J Med, 2016, 374(11): 1044-1052.
[19]
Vogel JP, Souza JP, Gülmezoglu AM, et al. Use of antenatal corticosteroids and tocolytic drugs in preterm births in 29 countries: an analysis of the WHO Multicountry Survey on Maternal and Newborn Health [J]. Lancet, 2014, 384(9957): 1869-1877.
[20]
van Vliet EO, Nijman TA, Schuit E, et al. Nifedipine versus atosiban for threatened preterm birth (APOSTEL III): a multicentre, randomised controlled trial [J]. Lancet, 2016, 387(10033): 2117-2124.
[21]
Rabe H, Diaz-Rossello JL, Duley L, et al. Effect of timing of umbilical cord clamping and other strategies to influence placental transfusion at preterm birth on maternal and infant outcomes [J]. Cochrane Database Syst Rev, 2012, 8(8): CD003248.
[22]
Rabe H, Reynolds G, Diazrossello J. A Systematic Review and Meta-Analysis of a Brief Delay in Clamping the Umbilical Cord of Preterm Infants [J]. Neonatology, 2008, 93(2): 138-144.
[23]
Tarnowmordi W, Morris J, Kirby A, et al. Delayed versus Immediate Cord Clamping in Preterm Infants [J]. N Engl J Med, 2017, 377(25): 265-266.
No related articles found!
阅读次数
全文


摘要